Torrent Pharmaceuticals Ltd has set a significant healthcare awareness record for the “Maximum Participation in Heart Rate Screening During World Hypertension Week,” with a total of 16,217 participants undergoing heart rate and blood pressure screening.
The record-setting initiative was conducted as part of a large-scale hypertension detection and awareness campaign, focusing on the importance of timely cardiovascular screening and better heart health.
A total of 16,217 participants took part in the campaign and underwent heart rate and blood pressure checks during World Hypertension Week. The initiative aimed to encourage individuals to regularly monitor important cardiovascular indicators and become more aware of factors associated with hypertension and heart health. By reaching thousands of participants, the campaign helped highlight the value of preventive screening and early identification of potential health concerns.
Heart rate and blood pressure are important indicators of cardiovascular health. Through the campaign, Torrent Pharmaceuticals sought to spread awareness about the importance of regular and timely screening as part of maintaining better overall heart health. The initiative encouraged participants to become more proactive about monitoring their health and seeking appropriate medical guidance whenever necessary.
Conducted during World Hypertension Week, the record-setting campaign also contributed to wider efforts aimed at improving public understanding of hypertension and its impact on cardiovascular health. With 16,217 participants undergoing heart rate and blood pressure screening, Torrent Pharmaceuticals Ltd established a notable healthcare awareness record while reinforcing the importance of early detection, regular monitoring and preventive heart care.
